Martin E. Keck
Max Planck Institute of Psychiatry
Kraepelinstr. 2-10
D-80804 Munich
Germany
Name/email consistency: high
- Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Keck, M.E., Sartori, S.B., Welt, T., Müller, M.B., Ohl, F., Holsboer, F., Landgraf, R., Singewald, N. J. Neurochem. (2005)
- Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders. Keck, M.E., Ohl, F., Holsboer, F., Müller, M.B. Neurosci. Biobehav. Rev (2005)
- Mutagenesis and knockout models: hypothalamic-pituitary-adrenocortical system. Keck, M.E., Müller, M.B. Handb. Exp. Pharmacol (2005)
- Challenge studies in anxiety disorders. Keck, M.E., Ströhle, A. Handb. Exp. Pharmacol (2005)
- Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders. Keck, M.E., Holsboer, F., Müller, M.B. Ann. N. Y. Acad. Sci. (2004)
- Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Keck, M.E., Welt, T., Müller, M.B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., Landgraf, R. Neuropsychopharmacology (2003)
- The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Keck, M.E., Welt, T., Müller, M.B., Landgraf, R., Holsboer, F. Pharmacopsychiatry (2003)
- rTMS as treatment strategy in psychiatric disorders--neurobiological concepts. Keck, M.E. Suppl. Clin. Neurophysiol (2003)
- Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Keck, M.E., Wigger, A., Welt, T., Müller, M.B., Gesing, A., Reul, J.M., Holsboer, F., Landgraf, R., Neumann, I.D. Neuropsychopharmacology (2002)
- Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Keck, M.E., Welt, T., Müller, M.B., Erhardt, A., Ohl, F., Toschi, N., Holsboer, F., Sillaber, I. Neuropharmacology (2002)
- The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats. Keck, M.E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., Landgraf, R. Eur. J. Neurosci. (2001)
- Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Keck, M.E., Welt, T., Post, A., Müller, M.B., Toschi, N., Wigger, A., Landgraf, R., Holsboer, F., Engelmann, M. Neuropsychopharmacology (2001)
- Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders. Keck, M.E., Holsboer, F. Peptides (2001)
- Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats. Keck, M.E., Hatzinger, M., Wotjak, C.T., Landgraf, R., Holsboer, F., Neumann, I.D. Eur. J. Neurosci. (2000)
- Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Keck, M.E., Sillaber, I., Ebner, K., Welt, T., Toschi, N., Kaehler, S.T., Singewald, N., Philippu, A., Elbel, G.K., Wotjak, C.T., Holsboer, F., Landgraf, R., Engelmann, M. Eur. J. Neurosci. (2000)
